Answers are grounded in this paper and cite their sources.
Despite new pharmacotherapy, most patients with long-term type 2 diabetes are still hyperglycemic. This could have been solved by insulin with its unlimited potential efficacy, but its dynamic physiology demands frequent titrations which are overdemanding. This report provides a real-life account for a scalable transformation of diabetes care in a community-based endocrinology center by harnessing artificial intelligence-based autonomous insulin titration.
No takes yet. Share an insight, caveat, or question.
Warren et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: